Home
- Naturade Significantly Strengthens Balance Sheet; Receives $2.5 Million in Capital from Westgate Equity Partners, L.P.
- Natrol Appoints Vincent Andrich VP Sales for Prolab Division
- Vermont Pure Holdings, Ltd. Announces Record Fiscal Year 2001 Results
- Body Shop Reports 24.8 Mil Euro Sales Revenues
- Supplement Group Targets Consumer Education
- Advanced Nutraceuticals, Inc. Announces 2001 Year End Results And Additional Financing
- ADM Awarded Nutraceuticals Patent Patent Creates Proprietary Position for ADM in Fast-Growing Nutraceutical Market
- Tantivy Sciences Obtains Exclusive License to Unique Nutraceutical Products
- Top GNC Executives Tour Pittsburgh Market to Present New Business Plan and Expansion Possibilities; Meeting will focus on new business strategies and growth
- Nutrition 21 Receives Patent For the Nutritional Treatment of Type 2 Diabetes; Patent Presents New Pharmaceutical Licensing Opportunities
- ConsumerLab.com Finds Most B-vitamin Supplements Contain What They Claim, But Often Exceed Safe Levels - Consumers Cautioned to Be Aware of Side Effects with High Dose Products
- Nutraceutix, Inc., Nutravite Announcement Commercial Availability of CDT™ Glucosamine for Canadian Marketplace
- Harvey Kamil Appointed President of NBTY, Inc. - Scott Rudolph to Continue as Chairman and CEO
- drugstore.com Expects to Reach Profitability Target in 2003
- Human Genome Project Leads to Innovative Healthcare
- NPIcenter’s Career Center targets nutraceutical Industry
- Adding Vitamin C To Certain Drugs May Help Treat Alzheimer's, Other Brain Disorders
- Adding Vitamin C To Certain Drugs May Help Treat Alzheimer's, Other Brain Disorders
- Editorial: An Exercise in Synergy
- NBTY, Inc. Appoints Harvey Kamil President, Scott Rudolph To Continue As Chairman And CEO
- Ross Products to Launch Infant Formula Supplemented With Two New Fatty Acids
- Ross Products to Launch Infant Formula Supplemented With Two New Fatty Acids
- Ross Products to Launch Infant Formula Supplemented With Two New Fatty Acids
- LignisulMSM vs Naproxen for Osteoarthritis Clinical Trial Gets Underway
- Natural Health Trends Corp. Launches Lexxus Taiwan
- New TrimFit® Bars Redefine Energy Bar Category
- New TrimFit® Bars Redefine Energy Bar Category
- Probiata® Offers Safe, Natural and Effective Alternative
- Alive & Well with Michelle Harris
- Be Well and Get Rewarded! Find Personalized Wellness Solutions and Earn Free Vitamins at NatureMade.com
- Consumers Search for Healthy Cleaning Products That Work
- Nordic Naturals: Omega 3 Fatty Acids
- Cyanotech Names Bob Capelli as Director of Sales
- Nutraceutical Clinical Laboratories International, Inc., Secures $2 Million in Funding
- KAVA ADVISORY: Health Canada is advising consumers not to use any products containing kava
- UK: Comments needed on phytosterol application
Lipofoods, has asked the UK Food Standards Agency's expert advisers on novel foods for an opinion on the ‘equivalence’ of a phytosterol ingredient to be used in various foods.
- UK: FSA Call for views on echium oil
The UK Food Standards Agency has received an application to use refined echium oil as a novel food ingredient.
- UK: FSA Call for views on echium oil
The UK Food Standards Agency has received an application to use refined echium oil as a novel food ingredient.
- UK: FSA Call for views on echium oil
The UK Food Standards Agency has received an application to use refined echium oil as a novel food ingredient.
- UK: FSA Call for views on echium oil
The UK Food Standards Agency has received an application to use refined echium oil as a novel food ingredient.
- UK: FSA Call for views on echium oil
The UK Food Standards Agency has received an application to use refined echium oil as a novel food ingredient.
- UK: FSA Call for views on echium oil
The UK Food Standards Agency has received an application to use refined echium oil as a novel food ingredient.
- UK: FSA Call for views on echium oil
The UK Food Standards Agency has received an application to use refined echium oil as a novel food ingredient.
- UK: FSA Call for views on echium oil
The UK Food Standards Agency has received an application to use refined echium oil as a novel food ingredient.
- Manufacturer of Ephedra-Based Dietary Supplements Settles Lawsuit with State
N.V.E. Pharmaceuticals, and Robert Occhifinto, the president of N.V.E., have settled a lawsuit that alleged the Sussex County manufacturer of dietary supplements misled consumers by making false and misleading claims about the safety and efficacy of its products. The settlement requires N.V.E. and Occhifinto to pay the State $260,000 as follows: a $60,000 payment from Occhifinto and four $50,000 payments from N.V.E.
- Manufacturer of Ephedra-Based Dietary Supplements Settles Lawsuit with State
N.V.E. Pharmaceuticals, and Robert Occhifinto, the president of N.V.E., have settled a lawsuit that alleged the Sussex County manufacturer of dietary supplements misled consumers by making false and misleading claims about the safety and efficacy of its products. The settlement requires N.V.E. and Occhifinto to pay the State $260,000 as follows: a $60,000 payment from Occhifinto and four $50,000 payments from N.V.E.
- FDA Notifies Consumers of Restitution Program for Purchases of Lane Labs' Products
The Food and Drug Administration (FDA) is notifying consumers of a restitution (refund) program for purchasers of three of Lane Labs-USA, Inc.'s products, BeneFin, MGN-3 and SkinAnswer, under which consumers who purchased those products between September 22, 1999 and July 12, 2004 are eligible for a partial refund of the purchase price and any shipping and handling costs.
- FDA Notifies Consumers of Restitution Program for Purchases of Lane Labs' Products
The Food and Drug Administration (FDA) is notifying consumers of a restitution (refund) program for purchasers of three of Lane Labs-USA, Inc.'s products, BeneFin, MGN-3 and SkinAnswer, under which consumers who purchased those products between September 22, 1999 and July 12, 2004 are eligible for a partial refund of the purchase price and any shipping and handling costs.
- Appeals Court Rules for FDA in Ephedra Ban: Overturns Lower Court Finding in Nutraceutical v. von Eschenbach
A three-judge panel of the 10th Circuit U.S. Court of Appeals ruled yesterday in favor of the U.S. Food and Drug Administration (FDA) in a case that had challenged the agency's 2004 prohibition of any level of ephedrine in dietary supplements. "The evidence in the administrative record was sufficiently probative to demonstrate by a preponderance of the evidence that EDS [ephedrine dietary supplements] at any dose level pose an unreasonable risk. The greater weight of the evidence supports the FDA’s ban on EDS, thus satisfying the agency's burden."
- Appeals Court Rules for FDA in Ephedra Ban: Overturns Lower Court Finding in Nutraceutical v. von Eschenbach
A three-judge panel of the 10th Circuit U.S. Court of Appeals ruled yesterday in favor of the U.S. Food and Drug Administration (FDA) in a case that had challenged the agency's 2004 prohibition of any level of ephedrine in dietary supplements. "The evidence in the administrative record was sufficiently probative to demonstrate by a preponderance of the evidence that EDS [ephedrine dietary supplements] at any dose level pose an unreasonable risk. The greater weight of the evidence supports the FDA’s ban on EDS, thus satisfying the agency's burden."
- Appeals Court Rules for FDA in Ephedra Ban: Overturns Lower Court Finding in Nutraceutical v. von Eschenbach
A three-judge panel of the 10th Circuit U.S. Court of Appeals ruled yesterday in favor of the U.S. Food and Drug Administration (FDA) in a case that had challenged the agency's 2004 prohibition of any level of ephedrine in dietary supplements. "The evidence in the administrative record was sufficiently probative to demonstrate by a preponderance of the evidence that EDS [ephedrine dietary supplements] at any dose level pose an unreasonable risk. The greater weight of the evidence supports the FDA’s ban on EDS, thus satisfying the agency's burden."
- FDA Statement on Tenth Circuit’s Ruling to Uphold FDA Decision Banning Dietary Supplements Containing Ephedrine Alkaloids
FDA states that no dosage of dietary supplements containing ephedrine alkaloids is safe and the sale of these products in the United States is illegal and subject to FDA enforcement action.
- FDA Statement on Tenth Circuit’s Ruling to Uphold FDA Decision Banning Dietary Supplements Containing Ephedrine Alkaloids
FDA states that no dosage of dietary supplements containing ephedrine alkaloids is safe and the sale of these products in the United States is illegal and subject to FDA enforcement action.
- FDA Statement on Tenth Circuit’s Ruling to Uphold FDA Decision Banning Dietary Supplements Containing Ephedrine Alkaloids
FDA states that no dosage of dietary supplements containing ephedrine alkaloids is safe and the sale of these products in the United States is illegal and subject to FDA enforcement action.
- FDA Statement on Tenth Circuit’s Ruling to Uphold FDA Decision Banning Dietary Supplements Containing Ephedrine Alkaloids
FDA states that no dosage of dietary supplements containing ephedrine alkaloids is safe and the sale of these products in the United States is illegal and subject to FDA enforcement action.
- Government of Canada Awards Site License to Sangster’s Health Centres
Sangster’s Health Centres, (a member of Planet Organic Health Corp. POH-TSX Venture Exchange), announces that Darwen Holdings, the product distribution division of Sangster’s Health Centres has been awarded a site license under The Government of Canada’s Natural Health Products Regulations (NHP).
- Government of Canada Awards Site License to Sangster’s Health Centres
Sangster’s Health Centres, (a member of Planet Organic Health Corp. POH-TSX Venture Exchange), announces that Darwen Holdings, the product distribution division of Sangster’s Health Centres has been awarded a site license under The Government of Canada’s Natural Health Products Regulations (NHP).
- Government of Canada Awards Site License to Sangster’s Health Centres
Sangster’s Health Centres, (a member of Planet Organic Health Corp. POH-TSX Venture Exchange), announces that Darwen Holdings, the product distribution division of Sangster’s Health Centres has been awarded a site license under The Government of Canada’s Natural Health Products Regulations (NHP).
- AHPA Submits Comments to US Forest Service on Native Plants Proposal
AHPA has submitted comments to the US Forest Service (USFS) last Friday, specifically to request that the term "native plant" be defined in language that is consistent with other federal definitions of the term, and to suggest greater clarity in a newly proposed policy statement. (May 26 USFS proposal to establish a new directive in Forest Service Manual 2070 for native plant materials.)
- AHPA Submits Comments to US Forest Service on Native Plants Proposal
AHPA has submitted comments to the US Forest Service (USFS) last Friday, specifically to request that the term "native plant" be defined in language that is consistent with other federal definitions of the term, and to suggest greater clarity in a newly proposed policy statement. (May 26 USFS proposal to establish a new directive in Forest Service Manual 2070 for native plant materials.)
- Consumer Protection Deputy Director To Leave FTC
C. Lee Peeler, deputy director of the Bureau of Consumer Protection for the past five years, will leave the FTC, to become president of the National Advertising Review Council and Executive Vice President for National Advertising and Self-Regulation of the Council of Better Business Bureaus.
- Consumer Protection Deputy Director To Leave FTC
C. Lee Peeler, deputy director of the Bureau of Consumer Protection for the past five years, will leave the FTC, to become president of the National Advertising Review Council and Executive Vice President for National Advertising and Self-Regulation of the Council of Better Business Bureaus.
- Consumer Protection Deputy Director To Leave FTC
C. Lee Peeler, deputy director of the Bureau of Consumer Protection for the past five years, will leave the FTC, to become president of the National Advertising Review Council and Executive Vice President for National Advertising and Self-Regulation of the Council of Better Business Bureaus.
- Consumer Protection Deputy Director To Leave FTC
C. Lee Peeler, deputy director of the Bureau of Consumer Protection for the past five years, will leave the FTC, to become president of the National Advertising Review Council and Executive Vice President for National Advertising and Self-Regulation of the Council of Better Business Bureaus.
- Consumer Protection Deputy Director To Leave FTC
C. Lee Peeler, deputy director of the Bureau of Consumer Protection for the past five years, will leave the FTC, to become president of the National Advertising Review Council and Executive Vice President for National Advertising and Self-Regulation of the Council of Better Business Bureaus.
- UK: Comments wanted on phytosterol
French company, DRT, has asked for a decision on its phytosterol ingredient, which is derived from tall oil pitch – a substance distilled from pine resin.
- UK: Comments wanted on phytosterol
French company, DRT, has asked for a decision on its phytosterol ingredient, which is derived from tall oil pitch – a substance distilled from pine resin.
- UK: Comments wanted on phytosterol
French company, DRT, has asked for a decision on its phytosterol ingredient, which is derived from tall oil pitch – a substance distilled from pine resin.
- UK: Comments wanted on phytosterol
French company, DRT, has asked for a decision on its phytosterol ingredient, which is derived from tall oil pitch – a substance distilled from pine resin.
- UK: Comments wanted on phytosterol
French company, DRT, has asked for a decision on its phytosterol ingredient, which is derived from tall oil pitch – a substance distilled from pine resin.
- Cargill Expands GRAS Status of Oliggo-Fiber® Inulin and Oligofructose Products
Company has expanded the GRAS (Generally Recognized As Safe) status of its Oliggo-Fiber® brand of inulin and oligofructose products through an independent evaluation by a qualified scientific expert, permitting the Oliggo-Fiber inulin and oligofructose line of products for general use in foods at levels consistent with current good manufacturing practice.
- Cargill Expands GRAS Status of Oliggo-Fiber® Inulin and Oligofructose Products
Company has expanded the GRAS (Generally Recognized As Safe) status of its Oliggo-Fiber® brand of inulin and oligofructose products through an independent evaluation by a qualified scientific expert, permitting the Oliggo-Fiber inulin and oligofructose line of products for general use in foods at levels consistent with current good manufacturing practice.
- Cargill Expands GRAS Status of Oliggo-Fiber® Inulin and Oligofructose Products
Company has expanded the GRAS (Generally Recognized As Safe) status of its Oliggo-Fiber® brand of inulin and oligofructose products through an independent evaluation by a qualified scientific expert, permitting the Oliggo-Fiber inulin and oligofructose line of products for general use in foods at levels consistent with current good manufacturing practice.
- Cargill Expands GRAS Status of Oliggo-Fiber® Inulin and Oligofructose Products
Company has expanded the GRAS (Generally Recognized As Safe) status of its Oliggo-Fiber® brand of inulin and oligofructose products through an independent evaluation by a qualified scientific expert, permitting the Oliggo-Fiber inulin and oligofructose line of products for general use in foods at levels consistent with current good manufacturing practice.
- Hi-Fil® Lutein Achieves GRAS Status
Hi-Fil® Lutein products, manufactured by Industrial Organica and distributed exclusively by Pharmline Inc., has attained self-affirmed GRAS (Generally Recognized As Safe) status, through an independent evaluation by an expert panel of scientists.
- Hi-Fil® Lutein Achieves GRAS Status
Hi-Fil® Lutein products, manufactured by Industrial Organica and distributed exclusively by Pharmline Inc., has attained self-affirmed GRAS (Generally Recognized As Safe) status, through an independent evaluation by an expert panel of scientists.
- Hi-Fil® Lutein Achieves GRAS Status
Hi-Fil® Lutein products, manufactured by Industrial Organica and distributed exclusively by Pharmline Inc., has attained self-affirmed GRAS (Generally Recognized As Safe) status, through an independent evaluation by an expert panel of scientists.
- Hi-Fil® Lutein Achieves GRAS Status
Hi-Fil® Lutein products, manufactured by Industrial Organica and distributed exclusively by Pharmline Inc., has attained self-affirmed GRAS (Generally Recognized As Safe) status, through an independent evaluation by an expert panel of scientists.
- Sabinsa Secures Approval From Government of India to Use Its Ocufors(TM) Eye Drop Solution for Glaucoma Treatment
Company has been granted permission by the Drugs Controller General of India to manufacture and market Ocufors(TM), an ophthalmic solution containing one percent forskolin, for the treatment of glaucoma.
- Sabinsa Secures Approval From Government of India to Use Its Ocufors(TM) Eye Drop Solution for Glaucoma Treatment
Company has been granted permission by the Drugs Controller General of India to manufacture and market Ocufors(TM), an ophthalmic solution containing one percent forskolin, for the treatment of glaucoma.
- Sabinsa Secures Approval From Government of India to Use Its Ocufors(TM) Eye Drop Solution for Glaucoma Treatment
Company has been granted permission by the Drugs Controller General of India to manufacture and market Ocufors(TM), an ophthalmic solution containing one percent forskolin, for the treatment of glaucoma.
- Sabinsa Secures Approval From Government of India to Use Its Ocufors(TM) Eye Drop Solution for Glaucoma Treatment
Company has been granted permission by the Drugs Controller General of India to manufacture and market Ocufors(TM), an ophthalmic solution containing one percent forskolin, for the treatment of glaucoma.
- GRAS Status Affirmed for Lipogen Phosphatidylserine
Company announces that FDA has no questions regarding the GRAS notification for its Lipogen PS (phosphatidylserine) patented product line.
- GRAS Status Affirmed for Lipogen Phosphatidylserine
Company announces that FDA has no questions regarding the GRAS notification for its Lipogen PS (phosphatidylserine) patented product line.
- GRAS Status Affirmed for Lipogen Phosphatidylserine
Company announces that FDA has no questions regarding the GRAS notification for its Lipogen PS (phosphatidylserine) patented product line.
- GRAS Status Affirmed for Lipogen Phosphatidylserine
Company announces that FDA has no questions regarding the GRAS notification for its Lipogen PS (phosphatidylserine) patented product line.
- NSF International Awards First GMP for Sport(TM) Registration to Century Foods International
NSF International announced that Century Foods International is the first manufacturing facility to receive Good Manufacturing Practices (GMP) for Sport™ registration, a new program that builds on NSF’s GMP Registration Program.
- NSF International Awards First GMP for Sport(TM) Registration to Century Foods International
NSF International announced that Century Foods International is the first manufacturing facility to receive Good Manufacturing Practices (GMP) for Sport™ registration, a new program that builds on NSF’s GMP Registration Program.
- NSF International Awards First GMP for Sport(TM) Registration to Century Foods International
NSF International announced that Century Foods International is the first manufacturing facility to receive Good Manufacturing Practices (GMP) for Sport™ registration, a new program that builds on NSF’s GMP Registration Program.
- NSF International Awards First GMP for Sport(TM) Registration to Century Foods International
NSF International announced that Century Foods International is the first manufacturing facility to receive Good Manufacturing Practices (GMP) for Sport™ registration, a new program that builds on NSF’s GMP Registration Program.
- NSF International Awards First GMP for Sport(TM) Registration to Century Foods International
NSF International announced that Century Foods International is the first manufacturing facility to receive Good Manufacturing Practices (GMP) for Sport™ registration, a new program that builds on NSF’s GMP Registration Program.
- NSF International Awards First GMP for Sport(TM) Registration to Century Foods International
NSF International announced that Century Foods International is the first manufacturing facility to receive Good Manufacturing Practices (GMP) for Sport™ registration, a new program that builds on NSF’s GMP Registration Program.
- FDA Asks U.S. Marshals to Seize Dietary Supplements Products Being Promoted With Drug Claims
At the request of the U.S. Food and Drug Administration (FDA), on September 5, 2006, U.S. Marshals seized quantities of Ellagimax capsules, Coral Max capsules, Coral Max without Iron capsules, and Advanced Arthritis Support capsules distributed by Advantage Nutraceuticals L.L.C. of Fort Walton Beach, Florida, valued at approximately $55,000.00. The products are alleged to be in violation of the new drug and misbranding provisions of the Federal Food, Drug and Cosmetic Act.
- FDA Asks U.S. Marshals to Seize Dietary Supplements Products Being Promoted With Drug Claims
At the request of the U.S. Food and Drug Administration (FDA), on September 5, 2006, U.S. Marshals seized quantities of Ellagimax capsules, Coral Max capsules, Coral Max without Iron capsules, and Advanced Arthritis Support capsules distributed by Advantage Nutraceuticals L.L.C. of Fort Walton Beach, Florida, valued at approximately $55,000.00. The products are alleged to be in violation of the new drug and misbranding provisions of the Federal Food, Drug and Cosmetic Act.
- FDA Asks U.S. Marshals to Seize Dietary Supplements Products Being Promoted With Drug Claims
At the request of the U.S. Food and Drug Administration (FDA), on September 5, 2006, U.S. Marshals seized quantities of Ellagimax capsules, Coral Max capsules, Coral Max without Iron capsules, and Advanced Arthritis Support capsules distributed by Advantage Nutraceuticals L.L.C. of Fort Walton Beach, Florida, valued at approximately $55,000.00. The products are alleged to be in violation of the new drug and misbranding provisions of the Federal Food, Drug and Cosmetic Act.
- FDA Asks U.S. Marshals to Seize Dietary Supplements Products Being Promoted With Drug Claims
At the request of the U.S. Food and Drug Administration (FDA), on September 5, 2006, U.S. Marshals seized quantities of Ellagimax capsules, Coral Max capsules, Coral Max without Iron capsules, and Advanced Arthritis Support capsules distributed by Advantage Nutraceuticals L.L.C. of Fort Walton Beach, Florida, valued at approximately $55,000.00. The products are alleged to be in violation of the new drug and misbranding provisions of the Federal Food, Drug and Cosmetic Act.
- FDA Asks U.S. Marshals to Seize Dietary Supplements Products Being Promoted With Drug Claims
At the request of the U.S. Food and Drug Administration (FDA), on September 5, 2006, U.S. Marshals seized quantities of Ellagimax capsules, Coral Max capsules, Coral Max without Iron capsules, and Advanced Arthritis Support capsules distributed by Advantage Nutraceuticals L.L.C. of Fort Walton Beach, Florida, valued at approximately $55,000.00. The products are alleged to be in violation of the new drug and misbranding provisions of the Federal Food, Drug and Cosmetic Act.
- DEA: Hi-Tech Pharmaceuticals & 11 Individuals Indicted for "Generic" Pill Fraud Scheme
Hi-Tech Pharmaceuticals & 11 Individuals have been indicted by a federal grand jury on multiple felony charges relating to a scheme to sell adulterated and unapproved new drugs over the internet.
- DEA: Hi-Tech Pharmaceuticals & 11 Individuals Indicted for "Generic" Pill Fraud Scheme
Hi-Tech Pharmaceuticals & 11 Individuals have been indicted by a federal grand jury on multiple felony charges relating to a scheme to sell adulterated and unapproved new drugs over the internet.
- Navamedic’s product Glucomed®/Flexove(TM) approved in EU by CHMP
Navamedic has received notice that its glucosamine HCl product Glucomed®/Flexove(TM) has been recommended for approval by the Committee for Medicinal Products for Human Use (CHMP). The approval will be valid for all 25 EU/EEA countries in Navamedic’s application.
- Navamedic’s product Glucomed®/Flexove(TM) approved in EU by CHMP
Navamedic has received notice that its glucosamine HCl product Glucomed®/Flexove(TM) has been recommended for approval by the Committee for Medicinal Products for Human Use (CHMP). The approval will be valid for all 25 EU/EEA countries in Navamedic’s application.
- Navamedic’s product Glucomed®/Flexove(TM) approved in EU by CHMP
Navamedic has received notice that its glucosamine HCl product Glucomed®/Flexove(TM) has been recommended for approval by the Committee for Medicinal Products for Human Use (CHMP). The approval will be valid for all 25 EU/EEA countries in Navamedic’s application.
- Navamedic’s product Glucomed®/Flexove(TM) approved in EU by CHMP
Navamedic has received notice that its glucosamine HCl product Glucomed®/Flexove(TM) has been recommended for approval by the Committee for Medicinal Products for Human Use (CHMP). The approval will be valid for all 25 EU/EEA countries in Navamedic’s application.
- Navamedic’s product Glucomed®/Flexove(TM) approved in EU by CHMP
Navamedic has received notice that its glucosamine HCl product Glucomed®/Flexove(TM) has been recommended for approval by the Committee for Medicinal Products for Human Use (CHMP). The approval will be valid for all 25 EU/EEA countries in Navamedic’s application.
- Ontario Government Closer to Regulating Traditional Chinese Medicine
Ontario has moved closer to regulating traditional Chinese medicine (TCM) and acupuncture as the proposed legislation moved to second reading.
- Frost & Sullivan Honours GAT Food Essentials GmbH With European Functional Food & Beverage Microencapsulation Technology Innovation Award
The 2009 Frost & Sullivan European Functional Food & Beverage Microencapsulation Technology Innovation Award has been presented to GAT Food Essentials GmbH in recognition of its proprietary wowCAPS(R) technology.
- Frost & Sullivan Honours GAT Food Essentials GmbH With European Functional Food & Beverage Microencapsulation Technology Innovation Award
The 2009 Frost & Sullivan European Functional Food & Beverage Microencapsulation Technology Innovation Award has been presented to GAT Food Essentials GmbH in recognition of its proprietary wowCAPS(R) technology.
- Frost & Sullivan Honours GAT Food Essentials GmbH With European Functional Food & Beverage Microencapsulation Technology Innovation Award
The 2009 Frost & Sullivan European Functional Food & Beverage Microencapsulation Technology Innovation Award has been presented to GAT Food Essentials GmbH in recognition of its proprietary wowCAPS(R) technology.
- BioExx Achieves Self-Affirmed GRAS Status for Protein Isolates
Bio-Extraction Inc., has announced that it has completed the self-affirmation process to qualify its specialty canola protein products, Isolexx(TM) and Vitalexx(TM), as self-affirmed GRAS for their intended use in various foods and beverages, thus providing a basis for the sale of these products in the United States when commercial production commences in Q1 2010.
- BioExx Achieves Self-Affirmed GRAS Status for Protein Isolates
Bio-Extraction Inc., has announced that it has completed the self-affirmation process to qualify its specialty canola protein products, Isolexx(TM) and Vitalexx(TM), as self-affirmed GRAS for their intended use in various foods and beverages, thus providing a basis for the sale of these products in the United States when commercial production commences in Q1 2010.
- BioExx Achieves Self-Affirmed GRAS Status for Protein Isolates
Bio-Extraction Inc., has announced that it has completed the self-affirmation process to qualify its specialty canola protein products, Isolexx(TM) and Vitalexx(TM), as self-affirmed GRAS for their intended use in various foods and beverages, thus providing a basis for the sale of these products in the United States when commercial production commences in Q1 2010.
- BioExx Achieves Self-Affirmed GRAS Status for Protein Isolates
Bio-Extraction Inc., has announced that it has completed the self-affirmation process to qualify its specialty canola protein products, Isolexx(TM) and Vitalexx(TM), as self-affirmed GRAS for their intended use in various foods and beverages, thus providing a basis for the sale of these products in the United States when commercial production commences in Q1 2010.
- BioExx Achieves Self-Affirmed GRAS Status for Protein Isolates
Bio-Extraction Inc., has announced that it has completed the self-affirmation process to qualify its specialty canola protein products, Isolexx(TM) and Vitalexx(TM), as self-affirmed GRAS for their intended use in various foods and beverages, thus providing a basis for the sale of these products in the United States when commercial production commences in Q1 2010.
- BioExx Achieves Self-Affirmed GRAS Status for Protein Isolates
Bio-Extraction Inc., has announced that it has completed the self-affirmation process to qualify its specialty canola protein products, Isolexx(TM) and Vitalexx(TM), as self-affirmed GRAS for their intended use in various foods and beverages, thus providing a basis for the sale of these products in the United States when commercial production commences in Q1 2010.
- BioExx Achieves Self-Affirmed GRAS Status for Protein Isolates
Bio-Extraction Inc., has announced that it has completed the self-affirmation process to qualify its specialty canola protein products, Isolexx(TM) and Vitalexx(TM), as self-affirmed GRAS for their intended use in various foods and beverages, thus providing a basis for the sale of these products in the United States when commercial production commences in Q1 2010.
- BioExx Achieves Self-Affirmed GRAS Status for Protein Isolates
Bio-Extraction Inc., has announced that it has completed the self-affirmation process to qualify its specialty canola protein products, Isolexx(TM) and Vitalexx(TM), as self-affirmed GRAS for their intended use in various foods and beverages, thus providing a basis for the sale of these products in the United States when commercial production commences in Q1 2010.
- BioExx Achieves Self-Affirmed GRAS Status for Protein Isolates
Bio-Extraction Inc., has announced that it has completed the self-affirmation process to qualify its specialty canola protein products, Isolexx(TM) and Vitalexx(TM), as self-affirmed GRAS for their intended use in various foods and beverages, thus providing a basis for the sale of these products in the United States when commercial production commences in Q1 2010.
- Synergy Flavors Invests in Sensory Flavor Profiling Research
Synergy Flavors has commissioned a new research program at North Carolina State University to study the sensory profiles of a range of protein ingredients.
- Synergy Flavors Invests in Sensory Flavor Profiling Research
Synergy Flavors has commissioned a new research program at North Carolina State University to study the sensory profiles of a range of protein ingredients.
- Synergy Flavors Invests in Sensory Flavor Profiling Research
Synergy Flavors has commissioned a new research program at North Carolina State University to study the sensory profiles of a range of protein ingredients.
- Synergy Flavors Invests in Sensory Flavor Profiling Research
Synergy Flavors has commissioned a new research program at North Carolina State University to study the sensory profiles of a range of protein ingredients.
- Synergy Flavors Invests in Sensory Flavor Profiling Research
Synergy Flavors has commissioned a new research program at North Carolina State University to study the sensory profiles of a range of protein ingredients.
- Beat Crazy Cocoa Prices with Synergy's Chocolate Flavors
Synergy Flavors Inc., has announced their chocolate flavors offer a versatile solution for cocoa reduction and can be used as cocoa extenders.
- Beat Crazy Cocoa Prices with Synergy's Chocolate Flavors
Synergy Flavors Inc., has announced their chocolate flavors offer a versatile solution for cocoa reduction and can be used as cocoa extenders.
- Beat Crazy Cocoa Prices with Synergy's Chocolate Flavors
Synergy Flavors Inc., has announced their chocolate flavors offer a versatile solution for cocoa reduction and can be used as cocoa extenders.
- Beat Crazy Cocoa Prices with Synergy's Chocolate Flavors
Synergy Flavors Inc., has announced their chocolate flavors offer a versatile solution for cocoa reduction and can be used as cocoa extenders.
- Beat Crazy Cocoa Prices with Synergy's Chocolate Flavors
Synergy Flavors Inc., has announced their chocolate flavors offer a versatile solution for cocoa reduction and can be used as cocoa extenders.
- Beat Crazy Cocoa Prices with Synergy's Chocolate Flavors
Synergy Flavors Inc., has announced their chocolate flavors offer a versatile solution for cocoa reduction and can be used as cocoa extenders.
- Beat Crazy Cocoa Prices with Synergy's Chocolate Flavors
Synergy Flavors Inc., has announced their chocolate flavors offer a versatile solution for cocoa reduction and can be used as cocoa extenders.
- NPI Daily - Top of The News for Nov. 20, 2009 - FDA Issues 22 Warning Letters to Website Operators
Frost & Sullivan Honours GAT Food Essentials GmbH With European Functional Food & Beverage Microencapsulation Technology Innovation Award; Synergy Flavors Invests in Sensory Flavor Profiling Research; FDA Issues 22 Warning Letters to Website Operators; Nordic Naturals Ultimate Omega™ First Fish Oil to Participate in NFL/NFLPA Sports Nutrition Label Certification Program; BioExx Achieves Self-Affirmed GRAS Status for Protein Isolates; New Organic Berry Whole Food Energy Bar from Amazing Grass Delivers Whole Food Nutrition; Beat Crazy Cocoa Prices with Synergy's Chocolate Flavors
- NPI Daily - Top of The News for Nov. 20, 2009 - FDA Issues 22 Warning Letters to Website Operators
Frost & Sullivan Honours GAT Food Essentials GmbH With European Functional Food & Beverage Microencapsulation Technology Innovation Award; Synergy Flavors Invests in Sensory Flavor Profiling Research; FDA Issues 22 Warning Letters to Website Operators; Nordic Naturals Ultimate Omega™ First Fish Oil to Participate in NFL/NFLPA Sports Nutrition Label Certification Program; BioExx Achieves Self-Affirmed GRAS Status for Protein Isolates; New Organic Berry Whole Food Energy Bar from Amazing Grass Delivers Whole Food Nutrition; Beat Crazy Cocoa Prices with Synergy's Chocolate Flavors
- Heart Health Alert: Niacin May Reverse Hardening of the Arteries
- Heart Health Alert: Niacin May Reverse Hardening of the Arteries
- Heart Health Alert: Niacin May Reverse Hardening of the Arteries
- Heart Health Alert: Niacin May Reverse Hardening of the Arteries
- Spotlight on Savory Side Dishes
- Spotlight on Savory Side Dishes
- Spotlight on Savory Side Dishes
- Another Reason to Choose Healthy Lifestyle Habits
- Another Reason to Choose Healthy Lifestyle Habits
|
Oils Available in Australia Through Pathway International
LYSAKER, Norway (August, 28, 2006) – EPAX AS, a world leading supplier of omega-3 concentrates, announced today that after 18 months of working closely with its Australian distributor Pathway International, the company has been granted regulatory approval from Australia’s Therapeutic Goods Administration (TGA). This approval allows EPAX’s range of omega-3 oils to be used in complementary medicine products in Australia.
The approval comes at a time of increasing consumer awareness of the health benefits of the omega-3 fatty acids EPA and DHA. There is now a substantial body of scientific evidence supporting the use of the omega-3 fatty acids EPA and DHA for cardiovascular health, joint health, mood health and brain health.
“The demand for omega-3 fatty acids is continuing to grow on a global basis,” said Bjorn Refsum, CEO of EPAX AS, “We are pleased customers in Australia will now have access to products from EPAX, as the company is known as one of the world’s leading suppliers of omega-3 concentrates.”
About EPAX AS
EPAX AS is headquartered in Lysaker, Norway and has a GMP-approved production facility in Alesund, Norway, which is approved for API production by the Norwegian Medicines Agency. EPAX AS offers concentrated Omega-3 EPA/DHA oils in the business-to-business segment under the brand name EPAX, available in a wide range of top quality formulas with different EPA/DHA ratios focused on specific health conditions. EPAX is also available in TG or EE versions, including TG oils that are available in a deodorized TG/N version, which is virtually without taste and smell. For further information on EPAX AS, its products or clinical studies visit www.epax.com or contact Gunilla Traberg at gunilla.traberg@epax.com.
# # #
Contact: Ove Wikstrom
+47 22 53 49 00
ove.wikstrom@epax.com
|